Artivion Inc(AORT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:01 PM ET (Korea 10/31 05:01)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.07 | Insider Own | 5.33% | Shs Outstand | 48.7M | Perf Week | -3.09% |
| Market Cap | 1.10B | Forward P/E | 78.2 | EPS next Y | 206.94% | Insider Trans | -4.97% | Shs Float | 46.2M | Perf Month | 2.96% |
| Enterprise Value | 1.43B | PEG | 2.6 | EPS next Q | -0.06 | Inst Own | 94.23% | Short Float | 8.09% | Perf Quarter | -17.8% |
| Income | -0.00B | P/S | 2.34 | EPS this Y | -228.57% | Inst Trans | 4.48% | Short Ratio | 5.97 | Perf Half Y | -37.64% |
| Sales | 0.47B | P/B | 2.47 | EPS next 5Y | 30.11% | ROA | -0.33% | Short Interest | 3.74M | Perf YTD | -50.49% |
| Book/sh | 9.15 | P/C | 14.24 | EPS past 3/5Y | - | ROE | -0.73% | 52W High | -53.2% ($48.25) | Perf Year | -50.54% |
| Cash/sh | 1.59 | P/FCF | - | Sales past 3/5Y | 12.04% 11.75% | ROIC | -0.37% | 52W Low | 17.85% ($19.16) | Perf 3Y | 79.35% |
| Dividend Est. | - | EV/EBITDA | 25.66 | EPS Y/Y TTM | 85.99% | Gross Margin | 61.17% | Volatility(W/M) | 4.08% 4.41% | Perf 5Y | 9.4% |
| Dividend TTM | - | EV/Sales | 3.04 | Sales Y/Y TTM | 16.4% | Oper. Margin | 6.63% | ATR (14) | 1.01 | Perf 10Y | 32.82% |
| Dividend Ex-Date | 2015/12/9 | Quick Ratio | 2.01 | EPS Q/Q | -1039.19% | Profit Margin | -0.67% | RSI (14) | 46.58 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.97 | Sales Q/Q | 11.32% | SMA20 | 0.97% ($22.36) | Beta | 1.3 | Target Price | $40.91 |
| Payout | - | Debt/Eq | 0.92 | Earnings | 2026/11/5 | SMA50 | -5.39% ($23.87) | Rel Volume | 1 | Prev Close | $23.44 |
| Employees | 1800 | LT Debt/Eq | 0.9 | EPS/Sales Surpr. | -11300% 4.8% | SMA200 | -23.17% ($29.39) | Avg Volume(3M) | 0.63M | Price | $22.58 |
| IPO | 1993/2/12 | Option/Short | Yes/Yes | Trades | 7604 | Volume | 627,420 | Change | -3.67% |
Artivion is a cardiac and vascular surgery medical device company focused on treating aortic diseases. The company supplies aortic stent grafts, On-X mechanical heart valves, surgical sealants, vascular grafts, and cardiac and vascular tissue preservation services to the global market. It is a specialty medical device company that provides surgeons with a broad range of aortic treatment solutions through its direct sales organization and distribution network spanning North America, Europe, Asia, and Latin America.
Over the past 1 year, on the lower side
53% below its 1-year high.
Traded about as much as usual. That is 100% of its average volume.
Next earnings report: November 5
5 days to go.
AORT keeps an operating profit but posts a net loss
Of every $100 in sales, $6.63 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -228.6% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $234. Peers typically go for $326.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be +9.4%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 94.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
SAWS AAM Sawgrass US Small Cap Quality Growth ETF 0.03% 
TFGZ Thornburg Focus Growth Fund 0.02% 
XHE State Street SPDR S&P Health Care Equipment ETF 0.02% 
HTEC ROBO Global Healthcare Technology and Innovation ETF 0.02% 
NANC Subversive Congressional Democrats Trading ETF 0.01% It ranks #37 of 142 in the industry
Based on market cap of $1B.
FAQ
What kind of company is AORT?
AORT belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of AORT?
The market cap of AORT is approximately $1.1B, ranking 2,498 within its sector.
What is the 52-week high and low for AORT?
AORT has recorded a 52-week high of $48.25 and a low of $19.16.
